Prognostic significance of sarcopenia as determined by bioelectrical impedance analysis in patients with advanced pancreatic cancer receiving gemcitabine plus nab‑paclitaxel: A retrospective study
Affiliations: Department of Gastroenterology, Yokohama City University Graduate School of Medicine, Yokohama, Kanagawa 236‑0004, Japan, Department of Gastroenterology, Hepatobiliary and Pancreatic Medical Oncology Division, Kanagawa Cancer Center, Yokohama, Kanagawa 241‑8515, Japan, Department of Gastrointestinal Surgery, Kanagawa Cancer Center, Yokohama, Kanagawa 241‑8515, Japan
- Published online on: September 8, 2022 https://doi.org/10.3892/ol.2022.13495
- Article Number: 375
Copyright: © Tozuka et al. This is an open access article distributed under the terms of Creative Commons Attribution License.